Statistics
Publications
23
Citations
751
H-Index
16
Active since
1987
Beverly A. Teicher is an author at Dana-Farber Cancer Institute specializing in medicine, oncology, and chemotherapy.
Publications per year
1987–2001
23
23
A phase I clinical trial of novobiocin, a modulator of alkylating agent cytotoxicity.
J P Eder, C Wheeler, Beverly A. Teicher et al. · PubMed · 1991 · 58 citations
Medicine, Oncology, Pharmacology +15
1–5 of 23